Mitral valve regurgitation, the leakage of blood back to the left atrium during systole, is a significant cause of morbidity and mortality. The current treatment options for symptomatic mitral regurgitation are mitral valve replacement and mitral valve repair. However, the operative mortality for both of these treatments remains substantial. Furthermore, these treatments are often not referred for elderly patients with comorbidities. Thus, there is a pressing need for less invasive, non-surgical treatments of mitral regurgitation.
- Bioengineering Division
Determining the Mechanical Properties of Coronary Sinus for Percutaneous Mitral Valve Repair
- Views Icon Views
- Share Icon Share
- Search Site
Pham, TM, Nguyen, XH, DeHerrera, M, & Sun, W. "Determining the Mechanical Properties of Coronary Sinus for Percutaneous Mitral Valve Repair." Proceedings of the ASME 2008 Summer Bioengineering Conference. ASME 2008 Summer Bioengineering Conference, Parts A and B. Marco Island, Florida, USA. June 25–29, 2008. pp. 709-710. ASME. https://doi.org/10.1115/SBC2008-193226
Download citation file: